Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Preston

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
NIDA Research Monograph|January 1, 1992
Assessment of buprenorphine in a drug discrimination procedure in humansG E Bigelow, K L Preston
NIDA Research Monograph|January 1, 1989
Evaluation of the abuse potential of picenadolD R Jasinski, K L Preston
Archives of General Psychiatry|April 18, 2000
Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenanceK L Preston, A Umbricht, D H Epstein
Biological Psychiatry|July 15, 1995
Buprenorphine for human immunovirus-positive opiate-dependent patientsI D Montoya, A Umbricht, K L Preston
Drug and Alcohol Dependence|January 1, 1991
Abuse potential and pharmacological comparison of tramadol and morphineK L Preston, D R Jasinski, M Testa
Gastrointestinal Endoscopy|July 1, 1994
Optimal bowel preparation for flexible sigmoidoscopy--are two enemas better than one?K L Preston, F E Peluso, F Goldner
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discriminationK L Preston, I A Liebson, G E Bigelow
Drug and Alcohol Dependence|February 1, 1990
Effects of sublingually given naloxone in opioid-dependent human volunteersK L Preston, G E Bigelow, I A Liebson
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedureH E Jones, G E Bigelow, K L Preston
Psychopharmacology|January 1, 1988
Buprenorphine and naloxone alone and in combination in opioid-dependent humansK L Preston, G E Bigelow, I A Liebson
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
NIDA Research Monograph|January 1, 1992
Assessment of buprenorphine in a drug discrimination procedure in humansG E Bigelow, K L Preston
NIDA Research Monograph|January 1, 1989
Evaluation of the abuse potential of picenadolD R Jasinski, K L Preston
Archives of General Psychiatry|April 18, 2000
Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenanceK L Preston, A Umbricht, D H Epstein
Biological Psychiatry|July 15, 1995
Buprenorphine for human immunovirus-positive opiate-dependent patientsI D Montoya, A Umbricht, K L Preston
Drug and Alcohol Dependence|January 1, 1991
Abuse potential and pharmacological comparison of tramadol and morphineK L Preston, D R Jasinski, M Testa
Gastrointestinal Endoscopy|July 1, 1994
Optimal bowel preparation for flexible sigmoidoscopy--are two enemas better than one?K L Preston, F E Peluso, F Goldner
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discriminationK L Preston, I A Liebson, G E Bigelow
Drug and Alcohol Dependence|February 1, 1990
Effects of sublingually given naloxone in opioid-dependent human volunteersK L Preston, G E Bigelow, I A Liebson
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedureH E Jones, G E Bigelow, K L Preston
Psychopharmacology|January 1, 1988
Buprenorphine and naloxone alone and in combination in opioid-dependent humansK L Preston, G E Bigelow, I A Liebson
Pageof 12